Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Seo

Showing results (81-90 of 162) with videos related to

Pageof 17
Sort By:
Clinical and Experimental Rheumatology|November 17, 2020
Efficacy of leflunomide in the treatment of vasculitisNoura Mustapha, Lillian Barra, Simon Carette, et al.
Annals of the Rheumatic Diseases|August 26, 2010
Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment IndexRavi Suppiah, Oliver Flossman, Chetan Mukhtyar, et al.
JCI Insight|August 26, 2020
Fc receptor-like 5 and anti-CD20 treatment response in granulomatosis with polyangiitis and microscopic polyangiitisKasia Owczarczyk, Matthew D Cascino, Cecile Holweg, et al.
ACR Open Rheumatology|November 18, 2021
Serum Biomarkers of Disease Activity in Longitudinal Assessment of Patients with ANCA-Associated VasculitisPaul A Monach, Roscoe L Warner, Robert Lew, et al.
Rheumatology (Oxford, England)|November 8, 2017
Evaluation of damage in giant cell arteritisTanaz A Kermani, Antoine G Sreih, David Cuthbertson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 27, 2018
The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated VasculitisRennie L Rhee, John C Davis, Linna Ding, et al.
The Journal of Rheumatology|April 3, 2016
The Birmingham Vasculitis Activity Score as a Measure of Disease Activity in Patients with Giant Cell ArteritisTanaz A Kermani, David Cuthbertson, Simon Carette, et al.
Seminars in Arthritis and Rheumatism|August 29, 2015
Vasculitis in patients with inflammatory bowel diseases: A study of 32 patients and systematic review of the literatureAlice Sy, Nader Khalidi, Natasha Dehghan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 19, 2016
Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient SubsetsEli M Miloslavsky, Na Lu, Sebastian Unizony, et al.
Journal of Autoimmunity|July 20, 2019
The association of serum interleukin-6 levels with clinical outcomes in antineutrophil cytoplasmic antibody-associated vasculitisAlvise Berti, Roscoe Warner, Kent Johnson, et al.
Pageof 17

Showing results (81-90 of 162) with videos related to

Sort By:
Pageof 17
Clinical and Experimental Rheumatology|November 17, 2020
Efficacy of leflunomide in the treatment of vasculitisNoura Mustapha, Lillian Barra, Simon Carette, et al.
Annals of the Rheumatic Diseases|August 26, 2010
Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment IndexRavi Suppiah, Oliver Flossman, Chetan Mukhtyar, et al.
JCI Insight|August 26, 2020
Fc receptor-like 5 and anti-CD20 treatment response in granulomatosis with polyangiitis and microscopic polyangiitisKasia Owczarczyk, Matthew D Cascino, Cecile Holweg, et al.
ACR Open Rheumatology|November 18, 2021
Serum Biomarkers of Disease Activity in Longitudinal Assessment of Patients with ANCA-Associated VasculitisPaul A Monach, Roscoe L Warner, Robert Lew, et al.
Rheumatology (Oxford, England)|November 8, 2017
Evaluation of damage in giant cell arteritisTanaz A Kermani, Antoine G Sreih, David Cuthbertson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 27, 2018
The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated VasculitisRennie L Rhee, John C Davis, Linna Ding, et al.
The Journal of Rheumatology|April 3, 2016
The Birmingham Vasculitis Activity Score as a Measure of Disease Activity in Patients with Giant Cell ArteritisTanaz A Kermani, David Cuthbertson, Simon Carette, et al.
Seminars in Arthritis and Rheumatism|August 29, 2015
Vasculitis in patients with inflammatory bowel diseases: A study of 32 patients and systematic review of the literatureAlice Sy, Nader Khalidi, Natasha Dehghan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 19, 2016
Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient SubsetsEli M Miloslavsky, Na Lu, Sebastian Unizony, et al.
Journal of Autoimmunity|July 20, 2019
The association of serum interleukin-6 levels with clinical outcomes in antineutrophil cytoplasmic antibody-associated vasculitisAlvise Berti, Roscoe Warner, Kent Johnson, et al.
Pageof 17